NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.59% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.45% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.35% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.35% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.16% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.05% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.48% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.36% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.82% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.78% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.72% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.37% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.22% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 2.15% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.15% |
VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.15% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 2.01% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 1.99% |
ARGX | Argen-X | Healthcare | Biotechnology | 1.92% |